Results of IDA-FLAG programme in the treatment of recurrent acute myeloblastic leukaemia--preliminary report.Włodzimierz Łuczyński, Katarzyna Muszyńska-Rosłan, Maryna Krawczuk-Rybak, Marta Kuźmicz, Anna Iwaszkiewicz-Pawłowska, Jacek Kaliszewski
Med Sci Monit 2001; 7(1): CR125-129 :: ID: 421175
BACKGROUND: Unsatisfactory treatment results of acute myeloblastic leukaemiainspire the search for new drugs, characterised by higher efficiency and lower toxicity. The aim of thestudy was the assessment of the efficiency and side effects associated with the implementation of IDA-FLAGprotocol.
MATERIAL AND METHODS: The assessment of treatment results and undesirable effects was basedon the material of 4 children with the relapse of acute myeloblastic leukaemia, after a total of 6 IDA-FLAGprotocols.
RESULTS: Complete remission was obtained in 2 (50%) children, with mean remission time of13.5 months. One of the children underwent the transplantation of haematopoietic cells from unrelateddonor. The main side effect observed was bone marrow aplasia. Leucopenia, granulocytopenia, thrombocytopeniaand anaemia persisted for approx. 20 days. Apart from haematological symptoms, the following were alsoobserved: the symptoms of intolerance after ARA-C, aspergillosis of paranasal sinuses and lungs and severecoagulation disorders.
CONCLUSION: IDA-FLAG protocol may be recommended for use in children with AMLrelapse and the undesirable effects observed are acceptable.
Keywords: acute myeloblastic leukaemia, children, fludarabine, IDA-FLAG
01 December 2021 : EditorialEditorial: SARS-CoV-2 Vaccine Responses and Breakthrough COVID-19
Med Sci Monit 2021; 27:e935624
03 December 2021 : Laboratory ResearchInfluenza and Influenza-Like Respiratory Virus Infections in Children During the 2019/20 Influenza Season a...
Med Sci Monit In Press; DOI: 10.12659/MSM.934862
08 November 2021 : Database AnalysisVirtual Screening and Molecular Docking to Study the Mechanism of Chinese Medicines in the Treatment of Cor...
Med Sci Monit In Press; DOI: 10.12659/MSM.934102
01 November 2021 : EditorialEditorial: What Can be Learned from National and International Vaccine Adverse Event Reporting Systems Duri...
Med Sci Monit 2022; 28:e935299
07 Dec 2021 : Review articleA Review of the Impact of Neutrophils and Neutrophil Extracellular Traps (NETs) on the Development of Aorti...
Med Sci Monit In Press; DOI: 10.12659/MSM.935134
07 Dec 2021 : Review articleAdie’s Pupil: A Diagnostic Challenge for the Physician
Med Sci Monit In Press; DOI: 10.12659/MSM.934657
06 Dec 2021 : Animal ResearchAstragalus Flavone Induces Proliferation and Differentiation of Neural Stem Cells in a Cerebral Infarction ...
Med Sci Monit In Press; DOI: 10.12659/MSM.933830
Most Viewed Current Articles
20 Mar 2020 : Clinical ResearchSocial Capital and Sleep Quality in Individuals Who Self-Isolated for 14 Days During the Coronavirus Diseas...
Med Sci Monit 2020; 26:e923921
15 Apr 2020 : Clinical ResearchPsychological Impact and Coping Strategies of Frontline Medical Staff in Hunan Between January and March 20...
Med Sci Monit 2020; 26:e924171
05 May 2020 : Review articleAn Evidence Based Perspective on mRNA-SARS-CoV-2 Vaccine Development
Med Sci Monit 2020; 26:e924700